(BHF) Brighthouse Financial - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US10922N1037
BHF: Annuities, Life, Insurance, Fixed, Indexed
Brighthouse Financial, Inc. (NASDAQ:BHF) is a leading provider of annuity and life insurance products in the United States, serving customers through three core segments: Annuities, Life, and Run-off. The Annuities segment offers a diverse range of products, including variable, fixed, index-linked, and income annuities, designed to meet contract holders needs for tax-deferred wealth accumulation, wealth transfer, and income security. The Life segment provides term, universal, whole, and variable life insurance products, focusing on policyholders needs for financial security and protected wealth transfer. The Run-off segment manages legacy products, including universal life with secondary guarantees, structured settlements, pension risk transfer contracts, company-owned life insurance policies, and funding agreements. Founded in 1863 and headquartered in Charlotte, North Carolina, Brighthouse Financial operates with a focus on delivering financial security and wealth protection solutions to its customers.
From a technical perspective, BHF is currently trading at $54.41, with a 20-day average volume of 856,649 shares. The stock has recently breached its 20-day SMA of $52.07 and is testing the 50-day SMA of $55.47. The 200-day SMA of $50.15 indicates long-term bullish momentum. The Average True Range (ATR) of 2.98 suggests moderate volatility. Based on these indicators, BHF is expected to consolidate in the near term, with potential resistance at $55.47 and support at $52.07.
Fundamentally, BHF has a market capitalization of $2.94 billion, with a trailing P/E of 10.92 and a forward P/E of 2.54, indicating undervaluation relative to future earnings expectations. The price-to-book (P/B) ratio of 0.59 suggests the stock is trading below its book value, while the price-to-sales (P/S) ratio of 0.47 reflects strong revenue efficiency. The return on equity (RoE) of 7.82% highlights moderate profitability. Considering these metrics, BHF is positioned for stable growth, supported by its diversified product portfolio and disciplined risk management.
3-Month Forecast: Based on
Additional Sources for BHF Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
BHF Stock Overview
Market Cap in USD | 2,941m |
Sector | Financial Services |
Industry | Insurance - Life |
GiC Sub-Industry | Life & Health Insurance |
IPO / Inception | 2017-07-17 |
BHF Stock Ratings
Growth Rating | 63.2 |
Fundamental | 5.59 |
Dividend Rating | 0.0 |
Rel. Strength | -1.66 |
Analysts | 2.7/5 |
Fair Price Momentum | 56.63 USD |
Fair Price DCF | - |
BHF Dividends
No Dividends PaidBHF Growth Ratios
Growth Correlation 3m | -72.1% |
Growth Correlation 12m | 73.5% |
Growth Correlation 5y | 48.3% |
CAGR 5y | 18.21% |
CAGR/Max DD 5y | 0.52 |
Sharpe Ratio 12m | 0.75 |
Alpha | 8.73 |
Beta | 1.007 |
Volatility | 44.67% |
Current Volume | 1387.6k |
Average Volume 20d | 927.8k |
As of May 01, 2025, the stock is trading at USD 58.22 with a total of 1,387,573 shares traded.
Over the past week, the price has changed by +11.47%, over one month by +0.40%, over three months by -5.66% and over the past year by +20.66%.
Neither. Based on ValueRay Fundamental Analyses, Brighthouse Financial is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 5.59 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BHF as of May 2025 is 56.63. This means that BHF is currently overvalued and has a potential downside of -2.73%.
Brighthouse Financial has received a consensus analysts rating of 2.70. Therefor, it is recommend to hold BHF.
- Strong Buy: 1
- Buy: 0
- Hold: 6
- Sell: 1
- Strong Sell: 2
According to ValueRays Forecast Model, BHF Brighthouse Financial will be worth about 61.2 in May 2026. The stock is currently trading at 58.22. This means that the stock has a potential upside of +5.05%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 59.3 | 1.9% |
Analysts Target Price | 52.4 | -10% |
ValueRay Target Price | 61.2 | 5% |